drugset / Trial / NCT00000317

Early Phase II Trials for Cocaine Medication Development - 1

NCT00000317

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to develop models for early Phase II testing of potential medications for cocaine dependence: amoxapine, risperidone and other agents. The study was a controlled pilot trial of risperidone in opiate-dependent patients on methadone maintenance. The study explored whether risperidone reduced cocaine use, cocaine craving, and cocaine subjective effects in patients on methadone maintenance who abused cocaine and whether it had an acceptable side effect profile. This

Timeline

Start
1996-08
Primary completion
1999-07
Completion
1999-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified 4 mg

Indications